SecBot SecBot

Interagency Patent Coordination and Improvement Act of 2025

H.R. 4570 Rep. Joe Neguse (D-CO-2) In committee
Bill text PDF
  1. Introduced Jul 21
  2. Committee Jul 21
  3. Passed House Next
  4. Passed Senate Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Jul 21, 2025Next: House vote
464d ago Jul 21, 2025: Referred to the House Committee on the Judiciary.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
1company, 5 filings
Subscribe to see spend
Member trades
0trades in the last 90 days
None in these companies
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

1 company
Companies by sector
Biotech & Pharma 1
Search all 1 companies, their asks and price moves Subscribe

Summary

Interagency Patent Coordination and Improvement Act of 2025

Full summary2 paragraphs

This bill establishes the Interagency Task Force on Patents to support coordination and communication between the U.S. Patent and Trademark Office (USPTO) and the Food and Drug Administration (FDA) on activities relating to patents for human drugs and biological products.

The task force's duties shall include sharing information about (1) the processes of each agency, including how each agency evaluates applications (e.g., patent applications at the USPTO and new drug applications at the FDA); and (2) new approvals of patents, human drugs, biological products, and new technologies. The task force must also establish a process that requires (1) the USPTO to request from the FDA information relating to certain patent applications to help patent examiners carry out their duties, (2) the FDA to provide such information to the USPTO, and (3) the USPTO to assist the FDA in its ministerial role of listing patents.

Library of Congress summary, Jul 21, 2025

Summary versions
  • Introduced in HouseJul 21, 2025

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.